Acknowledging the significant burden of melanoma and skin cancer in Australia, we are committed to developing a national, targeted melanoma and skin cancer screening program.

The current landscape for skin checks in Australia is confusing and inequitable. We note the tremendous efforts underway by many organisations, clinicians, researchers and the not-for-profit sector to raise awareness all around Australia of the importance of sun-safety and early detection. There has also been considerable discussion regarding the role and delivery of skin checks in Australia. Together, we want to establish a program that is equitable and effective in reducing melanoma and skin cancer morbidity and deaths in Australia.

This screening program will be:

• Targeted: We advocate for a risk-based approach to melanoma and skin cancer screening, tailored to those at highest risk, in order to maximise the effectiveness of the screening program and allocate resources effectively.
• Equitable and Accessible: We affirm our commitment to ensuring equity and accessibility in the proposed screening program. Every individual at high-risk in Australia, regardless of geographic location, socio-economic status, or cultural background, should have equal access to high-quality melanoma and skin cancer screening services.
• Evidence-and data-driven: We emphasise the importance of generating rigorous research and clinical trials to inform evidence-based and meaningful outcomes. Targeted research will provide data on the optimal use of new diagnostic technologies and screening strategies.
• Collaborative: We commit to fostering collaboration and partnership across the cancer sector from people affected by melanoma and skin cancer, organisations, researchers, health professionals, policymakers, non-government organisations, and government.
• Continuously Evaluated: We support the development of a nationally consistent evaluation framework to enable continuous monitoring and evaluation of the effectiveness of the screening program, to allow for adjustments as necessary to optimise outcomes and minimise potential harms.

We will work collaboratively to drive the necessary evidence and data, research the optimal use of new diagnostic technologies and service deliveries, and learn from existing national screening programs.

Together, we can reduce the burden of melanoma and skin cancer through prevention and early detection, while saving lives and improving the health of our nation.